CDC Releases Updated Recommendations for Treatment of Latent TB Infection
June 28, 2018 – 3HP for Latent TB Infection Treatment
CDC released updated recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks (3HP) for treatment of latent tuberculosis (TB) infection. The updated recommendations support expanded use of an effective, shorter, treatment regimen to reach even more people with latent TB infection. The 3HP regimen can help remove current barriers to latent TB treatment for both patients and providers.
View High Resolution Version
The 3HP regimen can help remove current barriers to latent TB treatment for both patients and providers. By supporting a shorter treatment timeframe, offering the option for self-administration, and reducing treatment costs (estimated $400 for self-administered 3HP, compared to an estimated $18,000 to treat TB disease), treatment completion and cure of latent TB infection can be improved.